Carl Zeiss is trading at 60.51 as of the 27th of February 2025; that is 2.04% increase since the beginning of the trading day. The stock's open price was 59.3. Carl Zeiss has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 28th of January 2025 and ending today, the 27th of February 2025. Click here to learn more.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. The company has 89.44 M outstanding shares. More on Carl Zeiss Meditec
Carl Zeiss Meditec [CZMWY] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.79 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Carl Zeiss's market, we take the total number of its shares issued and multiply it by Carl Zeiss's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Carl Zeiss Meditec classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 89.44 M outstanding shares.
Carl Zeiss Meditec has accumulated about 8.4 M in cash with 188.2 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Check Carl Zeiss Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Carl Zeiss without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Financial Widgets Now
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
When running Carl Zeiss' price analysis, check to measure Carl Zeiss' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carl Zeiss is operating at the current time. Most of Carl Zeiss' value examination focuses on studying past and present price action to predict the probability of Carl Zeiss' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carl Zeiss' price. Additionally, you may evaluate how the addition of Carl Zeiss to your portfolios can decrease your overall portfolio volatility.